Our results indicated that ADAMTS9-AS2 inhibits cell proliferation and decreases chemotherapy resistance of ccRCC, and the molecular mechanism underlying this function is clarified. Here, ADAMTS9 is linked to nonpapillary renal cell carcinoma.